Shadin Ghabra

Dr. Shadin Ghabra


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
RTRajiv Trehan
Rajiv Trehan
PHPatrick Huang
Patrick Huang
XZXiao Bin Zhu
Xiao Bin Zhu
XWXin Wang
Xin Wang
MSMarlaine Soliman
Marlaine Soliman
TGTim F. Greten
Tim F. Greten
Functional tumor-specific CD8+ T cells are essential for effective anti-tumor immune response and immune checkpoint inhibitor therapy. Here we show that, compared to other organ sites, primary, metastatic liver tumors in murine models contain a higher number of tumor-specific CD8+ T cells which are also dysfunctional. High-dimensional, multi-omic analysis of patient samples reveals a higher frequency of exhausted tumor-reactive CD8+ T cells and enriched interactions between these cells and SPP1+ macrophages in profibrotic, alpha-SMA rich regions specifically in the liver. Differential pseudotime trajectory inference analysis reveals that extrahepatic signaling promotes an intermediate cell (IC) population in the liver, characterized by co-expression of VISG4, CSF1R, CD163, TGF-βR, IL-6R, and SPP1. Analysis of premetastatic adenocarcinoma patient samples reveals enrichment of this population may predict liver metastasis. These findings suggest a mechanism by which extrahepatic tumors drive liver metastasis by promoting an IC population that inhibits tumor-reactive CD8+ T cell function.

13 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
YKYasuyuki Kamada
Yasuyuki Kamada
KHKoy Hid
Koy Hid
YYYutaka Yonemura
Yutaka Yonemura
PSPaul Sugarbaker
Paul Sugarbaker
SGShadin Ghabra
Shadin Ghabra
OGOlivier Glehen
Olivier Glehen
Background: We conducted this study to review the patient characteristics associated with long-term survival in patients with peritoneal metastases from colorectal cancer who underwent cytoreductive surgery (CRS). Methods: We retrospectively investigated patients with peritoneal metastases from CRC treated with curative intent surgery with or without hyperthermic intraperitoneal chemotherapy at 13 institutions worldwide between January 1985 and April 2015 and survived longer than five years after the first CRS for peritoneal metastases. Clinical and oncological features and therapeutic parameters were described and analyzed. Results: Two hundred six long-term survivors were available for study. The median peritoneal cancer index (PCI) of this cohort was 4 (interquartile range (IQR), 2–7), and the median score of the small bowel regions of the PCI (SB-PCI) was 0 (IQR, 0–2). Complete cytoreduction (CC-0) was achieved in 180 (87.4%) patients. Recurrence was observed in 122 (59.2%) patients at a median of 1.8 (IQR, 1.2–2.6) years. Conclusions: While most long-term survivors showed low PCI/SB-PCI and CCR-0, some had characteristics considered associated with poor prognosis. Curative intent treatments may be considered in well-informed and fit patients showing negative factors affecting survival outcome.

22 October 2024 in STAR Protocols
Verified
Journal Article
Open access
SGShadin Ghabra
Shadin Ghabra
RTRajiv Trehan
Rajiv Trehan
FRFrancisco Rodriguez-Matos
Francisco Rodriguez-Matos
CMChi Ma
Chi Ma
TGTim F. Greten
Tim F. Greten
We present a protocol to generate a liver tumor murine model utilizing orthotopic ultrasound-guided intrahepatic injections of tumor cells and a partial hepatectomy. We describe cell and animal preparation and ultrasound-guided intrahepatic injections. We then depict how to conduct a partial hepatectomy addressing solutions to potential problems. This approach introduces a rapid and reproducible orthotopic implantation model of liver tumor model in a minimally invasive manner, allowing the surgical procedure to be optimized with minimal intra-abdominal injury. For complete details on the use and execution of this protocol, please refer to Brown et al.1.

11 December 2024 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
KBKylynda C. Bauer
Kylynda C. Bauer
SGShadin Ghabra
Shadin Ghabra
CMChi Ma
Chi Ma
LCLee Chedester
Lee Chedester
TGTim F. Greten
Tim F. Greten
Both the prevalence and mortality of liver cancers continue to rise. Early surgical interventions, including liver transplantation or resection, remain the only curative treatment. Nerves in the periphery influence tumor growth within visceral organs. Emerging cancer neuroscience efforts linked parasympathetic vagus nerves with tumor pathology, underscoring the value of vagal nerve denervation methods within cancer mouse models. Here, we describe a selective hepatic vagotomy that largely maintains non-liver parasympathetic innervation in mice. To address vagal interactions in hepatic tumor pathology, we provide an adapted methodology utilizing an established liver metastatic model. We anticipate that this methodology will expand the burgeoning field of cancer neuroscience, enabling the study of the neuroimmune, neurometabolic, and/or nerve–microbiota interactions shaping liver cancer progression and treatment.

15 March 2022 in Journal of Surgical Oncology
Verified
Journal Article
Open access
PSPaul Sugarbaker
Paul Sugarbaker
SGShadin Ghabra
Shadin Ghabra

31 March 2023 in Journal of Trauma and Injury
Verified
Journal Article
Open access
PDF file
FAFatima Alharmoodi
Fatima Alharmoodi
SGShadin Ghabra
Shadin Ghabra
SASalem Alharthi
Salem Alharthi
Traumatic diaphragmatic hernia is among the most uncommon conditions after severe trauma, and it is associated with high morbidity and mortality. The diagnosis is difficult and might be missed, but a multimodal investigation might help in terms of diagnostic yield. In this case report, we present a missed right diaphragmatic rupture 14 years after the trauma.